Cagrilintide is an amylin analog, while Semaglutide is a GLP-1 receptor agonist. They act on different targets and belong to different classes, though they are sometimes studied together in metabolic research. Both are supplied for research use only.
Side by side
| Cagrilintide | Semaglutide | |
|---|---|---|
| Class | Amylin analog | GLP-1 receptor agonist |
| Target | Amylin pathway | GLP-1 receptor |
| Research area | Metabolic | Metabolic |
| Status | Research use only | Research use only |
Different targets, sometimes paired
The two are not variations of one another; they act on different pathways. Because those pathways are complementary in metabolic research, the two are sometimes studied together. This is different from a Semaglutide vs. Tirzepatide comparison, where both target GLP-1.
Browse research-grade peptides
Every Axis compound is third-party tested to 99.4%+ purity, with a certificate of analysis on every batch.
What to look for
A research-grade compound should ship with a batch-specific certificate of analysis documenting identity and purity.
Key takeaways
- Cagrilintide is an amylin analog.
- Semaglutide is a GLP-1 receptor agonist.
- They act on different targets but are sometimes studied together.
- Both are research compounds, supplied for research use only.
A note on research use
The peptides supplied by Axis Peptide Labs are reference compounds for laboratory and research use only. They are intended for qualified researchers working in academic, institutional, and analytical settings. They are not drugs, foods, cosmetics, or medical products, and they are not intended for human or veterinary consumption. Documented identity and documented purity are what matter most when sourcing a compound, both of which are published on the Axis certificates of analysis page.
